CN110583829A - Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat - Google Patents

Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat Download PDF

Info

Publication number
CN110583829A
CN110583829A CN201910889259.9A CN201910889259A CN110583829A CN 110583829 A CN110583829 A CN 110583829A CN 201910889259 A CN201910889259 A CN 201910889259A CN 110583829 A CN110583829 A CN 110583829A
Authority
CN
China
Prior art keywords
raw materials
tea
blood
uric acid
malt
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
CN201910889259.9A
Other languages
Chinese (zh)
Inventor
梁成福
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Zhongshan Sanzhihu Food Technology Co Ltd
Original Assignee
Zhongshan Sanzhihu Food Technology Co Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Zhongshan Sanzhihu Food Technology Co Ltd filed Critical Zhongshan Sanzhihu Food Technology Co Ltd
Priority to CN201910889259.9A priority Critical patent/CN110583829A/en
Publication of CN110583829A publication Critical patent/CN110583829A/en
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23F—COFFEE; TEA; THEIR SUBSTITUTES; MANUFACTURE, PREPARATION, OR INFUSION THEREOF
    • A23F3/00—Tea; Tea substitutes; Preparations thereof
    • A23F3/34—Tea substitutes, e.g. matè; Extracts or infusions thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/06—Fungi, e.g. yeasts
    • A61K36/07—Basidiomycota, e.g. Cryptococcus
    • A61K36/076—Poria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/48—Fabaceae or Leguminosae (Pea or Legume family); Caesalpiniaceae; Mimosaceae; Papilionaceae
    • A61K36/484—Glycyrrhiza (licorice)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/60—Moraceae (Mulberry family), e.g. breadfruit or fig
    • A61K36/605—Morus (mulberry)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/62—Nymphaeaceae (Water-lily family)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/72—Rhamnaceae (Buckthorn family), e.g. buckthorn, chewstick or umbrella-tree
    • A61K36/725—Ziziphus, e.g. jujube
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/185—Magnoliopsida (dicotyledons)
    • A61K36/73—Rosaceae (Rose family), e.g. strawberry, chokeberry, blackberry, pear or firethorn
    • A61K36/734—Crataegus (hawthorn)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
    • A61K36/18—Magnoliophyta (angiosperms)
    • A61K36/88—Liliopsida (monocotyledons)
    • A61K36/899—Poaceae or Gramineae (Grass family), e.g. bamboo, corn or sugar cane
    • A61K36/8998—Hordeum (barley)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0087—Galenical forms not covered by A61K9/02 - A61K9/7023
    • A61K9/0095—Drinks; Beverages; Syrups; Compositions for reconstitution thereof, e.g. powders or tablets to be dispersed in a glass of water; Veterinary drenches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/06—Antigout agents, e.g. antihyperuricemic or uricosuric agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/06—Antihyperlipidemics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Natural Medicines & Medicinal Plants (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Mycology (AREA)
  • Alternative & Traditional Medicine (AREA)
  • Microbiology (AREA)
  • Medical Informatics (AREA)
  • Botany (AREA)
  • Biotechnology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Rheumatology (AREA)
  • Pain & Pain Management (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Food Science & Technology (AREA)
  • Polymers & Plastics (AREA)
  • Medicines Containing Plant Substances (AREA)

Abstract

The invention discloses a novel substitutional tea for reducing blood sugar, blood pressure and uric acid and blood fat, which comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome, and the preparation method comprises the following steps: selecting purchased raw materials, cleaning the raw materials, and proportioning; drying, disinfecting and sterilizing the proportioned raw materials; respectively crushing the raw materials of each component, screening after crushing, and continuously crushing the screened unqualified raw materials; fully mixing the raw materials of each component by adopting a mixer; the mixed raw materials are added into an automatic packaging machine for packaging, the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film seal is closed; and (5) packing the packed tea package into a box. The tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.

Description

Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat
Technical Field
The invention belongs to the field of health-care tea, and particularly relates to novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat. Meanwhile, the invention also relates to a preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat.
Background
Hypertension, hyperglycemia (diabetes) and hyperlipidemia. They are "rich diseases" derived from modern society, and may exist alone or be related to each other. Such as: diabetes patients are easy to suffer from hypertension or hyperlipidemia at the same time, the hyperlipidemia is also a main factor for the formation and development of arteriosclerosis, and the blood vessel elasticity of the arteriosclerosis patients is poor to aggravate the increase of blood pressure. Therefore, when any one of the three diseases appears, the "three-high disease" is easily formed in the later period.
Hypertension, one of the most common epidemic diseases in the modern time, early-stage hypertension patients can show symptoms such as headache, dizziness, tinnitus, palpitation, dim eyesight, inattention, hypomnesis, numbness of hands and feet, fatigue, weakness, easy dysphoria and the like, the symptoms are mostly caused by higher nerve dysfunction, and the severity of the symptoms is inconsistent with the degree of increase of blood pressure. The late stage blood pressure is always kept at a high level and is accompanied by the appearance of damaged organs such as brain, heart, kidney and the like. These organ damage can be either direct damage from hypertension or indirectly through accelerated development of atherosclerotic disease. The early stages of these organ damage can be asymptomatic, eventually leading to dysfunction and even failure.
Hyperglycemia, the most common form of hyperglycemia, is diabetes. Diabetes is a chronic and lifelong disease, is a common disease seriously harming human health, and causes abnormal metabolism of nutrients such as carbohydrate, fat, protein and the like in vivo due to relative or absolute deficiency of insulin. The disease can cause various complications, and can cause systemic diseases when serious, which causes people to be disabled, blindness and even death. The symptoms of diabetes are "more than three and one less", i.e. polyuria, polydipsia, polyphagia and weight loss. Patients with hyperglycemia should pay attention to diet control, have low sugar and low salt content, strengthen exercise, and check blood sugar or high blood sugar again after a while, and also consider the drugs for reducing blood sugar.
Hyperlipidemia, hyperlipemia refers to high blood cholesterol or triglyceride or low high density lipoprotein cholesterol, and is called dyslipidemia in modern medicine. If the blood fat is too high, blood viscosity is easily caused, the blood is deposited on the blood vessel wall, atherosclerosis is gradually formed, the blood vessel is gradually blocked, the blood flow is slowed down, and the blood flow is interrupted when the blood flow is serious. The condition can cause coronary heart disease if occurring in the heart, cerebral apoplexy if occurring in the brain, visual deterioration and blindness if blocking the eyeground blood vessel, renal arteriosclerosis and renal failure if occurring in the kidney, limb necrosis and ulceration if occurring in the lower limb, and the like. In addition, hyperlipidemia can cause hypertension, gallstone and pancreatitis, and aggravate hepatitis, senile dementia, etc. For lowering blood lipid, vitamin C tablet, semen Ginkgo soft capsule, liquid calcium, etc. can be taken frequently.
The traditional hypoglycemic and antihypertensive drugs have large side effect and strong drug resistance, the more the drug content is, the higher the blood sugar and blood pressure is, the effective radical cure can not be realized, and complications are easy to cause in the later period and the cost is high.
Disclosure of Invention
The invention aims to provide a novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat, and aims to solve the problems in the background technology.
In order to achieve the purpose, the invention provides the following technical scheme:
a novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.
Preferably, the malt 2 parts includes raw malt 1 part and cooked malt 1 part.
A preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following steps:
s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;
s2, drying, disinfecting and sterilizing the proportioned raw materials;
s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;
s4, fully mixing the raw materials of the components by a mixer;
s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;
s6, packaging the packaged tea bags.
Preferably, the net content of each tea bag is 5 g.
Compared with the prior art, the invention has the beneficial effects that: the tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.
Detailed Description
In order to make the objects, technical solutions and advantages of the present invention more apparent, the present invention is further described in detail with reference to the following embodiments. It should be understood that the specific embodiments described herein are merely illustrative of the invention and are not intended to limit the invention.
A novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.
Preferably, the malt 2 parts includes raw malt 1 part and cooked malt 1 part.
A preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat comprises the following steps:
s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;
s2, drying, disinfecting and sterilizing the proportioned raw materials;
s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;
s4, fully mixing the raw materials of the components by a mixer;
s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;
s6, packaging the packaged tea bags.
Preferably, the net content of each tea bag is 5g, and each box contains 33 bags.
The tea is replaced by the tea, so that the tea can be drunk by patients every day, is convenient, has no side effect, can be drunk by both the old and the young, and has lower cost.
The daily dose is 2-4 bags, each bag is boiled with 200ml of water and brewed, drinking is carried out after a few minutes, drinking 6 bags is taken as a course of treatment, and the practice proves that the traditional Chinese medicine can treat both symptoms and root causes and has good effect.
The above description is only for the preferred embodiment of the present invention, but the scope of the present invention is not limited thereto, and any person skilled in the art should be considered to be within the technical scope of the present invention, and the technical solutions and the inventive concepts thereof according to the present invention should be equivalent or changed within the scope of the present invention.

Claims (4)

1. A novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat is characterized by comprising the following raw materials in parts by weight: 1 part of lotus leaf, 1 part of hawthorn, 1 part of tuckahoe, 0.5 part of Chinese date, 1 part of mulberry leaf, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of reed rhizome.
2. The novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat as claimed in claim 1, is characterized in that: the malt 2 parts includes raw malt 1 part and cooked malt 1 part.
3. The preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat as defined in claim 1, which comprises the following steps:
s1, selecting and purchasing raw materials, cleaning the raw materials, and proportioning 1 part of lotus leaves, 1 part of hawthorn, 1 part of poria cocos, 0.5 part of Chinese dates, 1 part of mulberry leaves, 2 parts of malt, 0.5 part of fructus cannabis, 0.5 part of liquorice and 1 part of rhizoma phragmitis;
s2, drying, disinfecting and sterilizing the proportioned raw materials;
s3, crushing the raw materials of each component respectively, screening after crushing, and continuing crushing the screened unqualified raw materials;
s4, fully mixing the raw materials of the components by a mixer;
s5, adding the mixed raw materials into an automatic packaging machine for packaging, wherein the packaging bag is divided into two layers, the inner layer is a tea making bag, the outer layer is an aluminum film, and the aluminum film is sealed and sealed;
s6, packaging the packaged tea bags.
4. The preparation method of the novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat according to claim 3, which is characterized in that: the net content of each tea bag is 5 g.
CN201910889259.9A 2019-09-19 2019-09-19 Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat Pending CN110583829A (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
CN201910889259.9A CN110583829A (en) 2019-09-19 2019-09-19 Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
CN201910889259.9A CN110583829A (en) 2019-09-19 2019-09-19 Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat

Publications (1)

Publication Number Publication Date
CN110583829A true CN110583829A (en) 2019-12-20

Family

ID=68861487

Family Applications (1)

Application Number Title Priority Date Filing Date
CN201910889259.9A Pending CN110583829A (en) 2019-09-19 2019-09-19 Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat

Country Status (1)

Country Link
CN (1) CN110583829A (en)

Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101797346A (en) * 2010-04-19 2010-08-11 广西南宁健铧保健品有限公司 Qiqing traditional Chinese medicine tea for lowering blood pressure, lowering blood lipid and lowering blood sugar level and preparation method thereof
CN103285227A (en) * 2013-05-31 2013-09-11 浙江工业大学 Hypoglycemic Chinese medicine composition, hypoglycemic tea and preparation method of hypoglycemic tea
CN103446426A (en) * 2013-01-14 2013-12-18 贾晋科 Chinese medicine tea capable of lowering blood pressure and reducing blood fat
CN104012729A (en) * 2014-06-11 2014-09-03 杨平 Tea substitute bag capable of lowering uric acid
CN104642654A (en) * 2014-12-30 2015-05-27 韩超央 Health tea for controlling body weight, reducing uric acid and reducing hypertension, hyperglycemia and hyperlipemia
CN104920707A (en) * 2015-05-05 2015-09-23 禹州市鼎信中药科技有限公司 A lotus leaf and haw tea substitute and a preparation method thereof
CN105148133A (en) * 2015-09-30 2015-12-16 杭州麟莱进出口有限公司 Traditional Chinese medicine tea for treating hypertension, hyperlipidemia, hyperglycemia and hyperuricemia
CN107050324A (en) * 2017-01-26 2017-08-18 赵杏珍 A kind of integration of drinking and medicinal herbs Chinese medicine function health toxin expelling drink for preventing and treating gout and three high drop
CN109316566A (en) * 2018-11-30 2019-02-12 湖北仙芝堂生物科技有限公司 It is a kind of can be with the production method of anti-trioxypurine alternative tea

Patent Citations (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN101797346A (en) * 2010-04-19 2010-08-11 广西南宁健铧保健品有限公司 Qiqing traditional Chinese medicine tea for lowering blood pressure, lowering blood lipid and lowering blood sugar level and preparation method thereof
CN103446426A (en) * 2013-01-14 2013-12-18 贾晋科 Chinese medicine tea capable of lowering blood pressure and reducing blood fat
CN103285227A (en) * 2013-05-31 2013-09-11 浙江工业大学 Hypoglycemic Chinese medicine composition, hypoglycemic tea and preparation method of hypoglycemic tea
CN104012729A (en) * 2014-06-11 2014-09-03 杨平 Tea substitute bag capable of lowering uric acid
CN104642654A (en) * 2014-12-30 2015-05-27 韩超央 Health tea for controlling body weight, reducing uric acid and reducing hypertension, hyperglycemia and hyperlipemia
CN104920707A (en) * 2015-05-05 2015-09-23 禹州市鼎信中药科技有限公司 A lotus leaf and haw tea substitute and a preparation method thereof
CN105148133A (en) * 2015-09-30 2015-12-16 杭州麟莱进出口有限公司 Traditional Chinese medicine tea for treating hypertension, hyperlipidemia, hyperglycemia and hyperuricemia
CN107050324A (en) * 2017-01-26 2017-08-18 赵杏珍 A kind of integration of drinking and medicinal herbs Chinese medicine function health toxin expelling drink for preventing and treating gout and three high drop
CN109316566A (en) * 2018-11-30 2019-02-12 湖北仙芝堂生物科技有限公司 It is a kind of can be with the production method of anti-trioxypurine alternative tea

Similar Documents

Publication Publication Date Title
CN103891963B (en) Hypoglycemic health protection tea of a kind of reducing blood pressure and blood fat and preparation method thereof
CN102634441B (en) A kind of preparation method of health-care vinegar
CN103190659A (en) Plant beverage with pressure-drop, lipid-reducing, and hypoglycemic effects as well as preparation method and application thereof
CN103229875B (en) Three-flower warming tea beverage and production method thereof
CN105535654A (en) Wild cyclocarya paliurus compound healthcare wine and preparation method thereof
CN106581290A (en) Chinese magnoliavine fruit decoction for preventing and/or treating vision fatigue and preparation method of decoction
CN101543295B (en) Health care tea for reducing blood pressure and blood fat
CN1943376A (en) A kind of mountain chrysanthemum bagged tea and preparation method thereof
CN101978887A (en) Health-care food with auxiliary lipid-lowering efficacy
CN102246868A (en) Healthy tea for preventing and controlling arteriosclerosis
CN110583829A (en) Novel substitutional tea for reducing blood sugar, blood pressure, uric acid and blood fat
KR102112599B1 (en) Anti-obesity composition comprising Punica granatum and Citrus junos extract as effective component
JPH0923851A (en) Health food for quiet sleep
CN105709102A (en) Herbaceous plant composition for reducing blood fat
CN1144528C (en) Prescription and process for preparing bag tea
CN102210363B (en) Beverage capable of reducing blood pressure, blood fat and blood viscosity and preparation method
CN107029122B (en) A kind of pharmaceutical composition for treating hypertension and preparation method thereof, preparation and application
CN104522211A (en) Lingyuan Wanying medicinal tea drink and production technology thereof
CN111839131A (en) A medicated pillow for adjuvant treatment of hypertension
CN101837104B (en) Hyperlipidemia treating capsules
CN104825654A (en) Lipid-lowering tea
CN103070440B (en) Chinese yam and Tie Guanyin composite health-care beverage and making method of Chinese yam and Tie Guanyin composite health-care beverage
KR101118047B1 (en) An oriental drink comprising a phyllostachys bambusoides, a barley sprout, a yacon strawberry and a mulberry leaves
CN1660207A (en) Preparation of health care for reducing blood fat and cholesterol, and producing method
CN108478706A (en) It is a kind of to protect cardiovascular composition and preparation method thereof

Legal Events

Date Code Title Description
PB01 Publication
PB01 Publication
SE01 Entry into force of request for substantive examination
SE01 Entry into force of request for substantive examination
RJ01 Rejection of invention patent application after publication
RJ01 Rejection of invention patent application after publication

Application publication date: 20191220